Dr. Peter Goadsby has joined the Central Nervous System advisory board of Vial, a worldwide, tech-enabled CRO offering next-generation clinical trial administration services. Dr. Goadsby is a professor of neurology at the University of California, San Francisco and the Director of the NIHR Wellcome Trust at the King’s College Clinical Research Facility in London.

Dr. Goadsby is a well-known expert in headache medicine whose clinical research focuses on comprehending the pathophysiology of migraine and cluster headaches and directing treatment. By influencing the current standard of care for cluster headaches, his study has had a considerable impact on the area of neurology and contributed to a deeper understanding of the causes of migraine headaches.

The neuroscience research of Dr. Goadsby has received numerous honours and awards. For his research on the role of CGRP in migraine development, he and three of his colleagues were awarded the renowned Brain Prize, the largest award for brain research in the world, in 2021 by the Lundbeck Foundation.

Source: Prnewswire